This annual report documents vaccination coverage in NSW for children, adolescents and the elderly, up to and including data for 2017. Methods: Data from the Australian Immunisation Register (AIR), the NSW School Vaccination Program and the NSW Population Health Survey were used to calculate measures of population vaccination coverage. Vaccination timeliness for Aboriginal and non-Aboriginal children was also assessed using AIR data. Results: In 2017, 'fully immunised' coverage at 12 and 60 months of age remains greater than 93% for children in NSW. Following the change in algorithm for 'fully immunised' coverage at 24 months of age (amended in October 2016 to include the fourth dose of diphtheria, tetanus, and acellular pertussis-containing vaccine given at 18 months of age), dropped to just below 90%. Coverage was greater than 93% for vaccines/antigens due at the 12 and 60 month milestones, except for the second dose of rotavirus vaccine at 12 months of age, which increased to just below 91% in 2017. Coverage was greater than 94% for vaccines/antigens due at the 24-month milestone, except for the fourth dose of diphtheria, tetanus, and acellular pertussis-containing vaccine (92.3%), the second dose of the measles, mumps and rubella-containing vaccine (92.9%) and the varicella-containing vaccine (92.6%). At each milestone, 'fully immunised' coverage was higher in Aboriginal children compared with non-Aboriginal children in NSW. However, on-time vaccination of the first and third dose of diphtheria, tetanus, and acellular pertussis-containing vaccine and the second dose of the measles, mumps and rubellacontaining vaccine was still less than optimal for Aboriginal children. In 2017, 86% of Year 7 female students and 84% of Year 7 male students received a first dose of human papillomavirus vaccine, with 81% of females and 78% of males completing the two-dose course.
Introduction
This is the 9th annual immunisation coverage report for NSW, with analysis encompassing the years 2000-2017. These annual reports provide important information on trends and issues in vaccination coverage and facilitate the monitoring of NSW vaccination programs.
This report uses the longstanding international practice of reporting coverage at key milestone ages to measure coverage against national benchmarks and to track trends over time. It is adapted from annual national immunisation reports published since 2009. 1 High levels of reporting to the Australian Immunisation Register (AIR), previously known as the Australian Childhood Immunisation Register (ACIR), are maintained for childhood vaccinations by a system of incentive payments for immunisation providers and parents/guardians. 2 Reported vaccination coverage may be impacted by changes to immunisation policy, the incentive payment system and changes to the 'fully immunised' coverage algorithms. Some of these changes are highlighted in Box 1 and are also referred to in this report.
The ACIR was established on 1 January 1996 by incorporating demographic data from Medicare on all enrolled children aged less than 7 years. 8 Up to 31 December 2015, all vaccination records for a child remained on the register indefinitely, but no new vaccination encounter records were added after the 7th birthday.
2 From 1 January 2016, the register was changed to include records of vaccinations given up to less than 20 years of age and was further expanded from 30 September 2016 to become the AIR that captures records of vaccinations given to eligible individuals in Australia throughout their life. 9 Participation in the AIR is opt-out so it constitutes a nearly complete population register. Persons not enrolled in Medicare can be added to the AIR via a supplementary number. Since 2001, vaccinations given overseas may be recorded if a provider endorses their validity. Data are transferred to the AIR when a recognised immunisation provider supplies details of an eligible vaccination.
This can be done electronically, e.g. via medical practice software, through direct data entry on the AIR website or by submitting paper encounter or history forms. Medical contraindications or natural immunity to certain diseases, based on guidance from the Australian Immunisation Handbook 10 and a vaccination provider factsheet, 5 can only be reported by general practitioners using the AIR Medical Exemption Form. 11 All vaccination records for a person remain on the register indefinitely. As of 1 January 2016, conscientious objection to vaccination was no longer recorded on the AIR. Table 1 outlines vaccines delivered through the NSW Immunisation Program in 2017. The adolescent vaccination schedule of the NSW immunisation program underwent two significant changes in 2017. First, HPV vaccination for Year 7 students changed from a three-dose schedule to a two-dose schedule. This change was based on international evidence demonstrating that two vaccine doses given at least 6 months apart to adolescents aged 9-14 years provides an equivalent immunologic response to three doses. 12, 13 Second, in response to the emergence of meningococcal serogroup W as a significant cause of Box 1. Selected recent and significant changes in immunisation policy, immunisation incentives and coverage calculation algorithms relevant to NSW invasive meningococcal disease in Australia, the NSW Meningococcal W Response Program implemented meningococcal ACWY vaccination targeted at older adolescents in Years 11 and 12 from 1 May 2017. 14 
Methods

Measuring vaccination coverage using the Australian Immunisation Register
This report details vaccination coverage for 2017 using AIR data up to 31 March 2018. The cohort method has been used for calculating coverage at the population level (national and state/territory) 15 since the inception of the immunisation register. Cohort vaccination status was assessed at 12 months of age (for vaccines due at 6 months), 24 months of age (for vaccines due at 12 and 18 months), and 60 months of age (for vaccines due at 48 months). A 3-month lag period was allowed for the late notification of vaccinations to the AIR. 15 If a child's record indicates receipt of the last dose of a vaccine that requires more than one dose to complete the series, it was assumed that earlier vaccinations in the sequence had been given. This assumption has been shown to be valid. 16, 17 The proportion of children designated as 'fully immunised' was calculated using 12-month-wide cohorts with the number of children completely vaccinated with the vaccines of interest by the designated age as the numerator, and the total number of Medicare-registered children in the age cohort as the denominator. The 12-month-wide cohorts used were children born between 1 January 2016 and 31 December 2016 for the 12-month milestone, between 1 January 2015 and 31 December 2015 for the 24-month milestone, and between 1 January 2012 and 31 December 2012 for the 5-year (60-month) milestone. 'Fully immunised' at 12 months of age was defined as a child having a record on the AIR of a third dose of DTPa-containing vaccine, a third dose of polio-containing, Haemophilus influenzae type b (Hib)-containing and hepatitis B-containing vaccines (predominantly given as the combined DTPa-hepB-IPV-Hib vaccine), and a third dose of 13-valent PCV. Vaccination coverage estimates were also calculated at the 12-month milestone for the second dose of rotavirus vaccine, a National Immunisation Program (NIP) vaccine that is not included in calculations for incentive payments and 'fully immunised' status. In March 2016, an additional booster (fourth dose) of DTPa at 18 months of age was added to the NIP and has been included in the algorithm for 'fully immunised' at 24 months of age since 1 October 2016. As such, 'fully immunised' at 24 months of age was defined as a child having a record on the AIR of a fourth dose of DTPa-containing vaccine, a third dose of polio-containing and hepatitis B-containing vaccines, a fourth dose of Hib-containing vaccine (or a third dose of the Haemophilus B conjugate (PRP-T) vaccine if given after 11.5 months of age), a second dose of MMR-containing vaccine, a first dose of varicella-containing vaccine and a first dose of meningococcal C-containing vaccine. 'Fully immunised' at 60 months of age was defined as a child having a record on the AIR of a fourth or fifth dose of DTPa-containing vaccine, a fourth dose of poliocontaining vaccine and a second dose of MMR-containing vaccine.
Timeliness
Age-appropriate and timely vaccination was defined as receipt of a scheduled vaccine dose within 30 days of the recommended age for administration. Timeliness of the first and third dose of DTPa-containing vaccine and of the second dose of MMR-containing vaccine was measured using 12-month-wide birth cohorts. However, children included in the timeliness analysis were assessed at 1-,3 years after doses were due, to allow time for late vaccinations to be recorded. Therefore, these cohorts were not the same as those assessed for coverage milestones.
Aboriginal and non-Aboriginal timeliness of the first dose of DTPa-containing vaccine in 2017 was compared by plotting the cumulative percentage receiving the dose by age. Trends in the percentage of Aboriginal and nonAboriginal children vaccinated on-time for the third dose of DTPa-containing vaccine and the second dose of MMRcontaining vaccine were plotted for 2008-2017. The delay outcome measure for these vaccine doses in 2017 was also categorised as 'no delay', 'delay of 1-,3 months', delay of 3-,7 months or 'delay $7 months' for both Aboriginal and non-Aboriginal children.
Local health districts
Vaccination coverage estimates and vaccination delay estimates are presented in this report for NSW and by NSW local health district (LHD). LHDs were introduced in January 2011, replacing area health services. There are 15 geographically based LHDs in NSW -eight in metropolitan NSW and seven in rural and regional NSW. Data for an additional LHD (Network with Victoria) is also reported on.
Aboriginal status
Indigenous status on the AIR is recorded nationally as 'Indigenous', 'non-Indigenous' or 'unknown', as reported by the child's carer to Medicare, or by the immunisation provider to the AIR. For this report, two categories of children were considered: 'Aboriginal' (Indigenous) and 'non-Aboriginal' (non-Indigenous). As the completeness of Aboriginal identification in the register increased substantially after 2005, 18 the 0.4% of children whose Aboriginal status was not specified were presumed to be nonAboriginal for the purposes of the analyses conducted for this report.
Small area coverage
Coverage was calculated by Australian Bureau of Statistics (ABS)-defined statistical area level 3 (SA3), which forms part of the Australian Statistical Geography Standard (ASGS).
19 SA3s were chosen as areas to be mapped because they provide more detail than LHDs but are not too small to render maps unreadable (population sizes for a year-wide birth cohort of children for SA3s in NSW range from 110 to 2799 children). SA3s with a population size for a year-wide birth cohort of children less than 26 were excluded from any mapping due to the imprecision of any coverage estimates calculated for these areas. Maps were created using MapInfo mapping software 20 and the ABS Census Boundary Information. As postcode is the only geographical indicator on the AIR, the ABS Postal Area to SA3 Concordance 2011 was used to match children's residential postcodes to SA3s. 21 (Table 2) . At this milestone, 'fully immunised' coverage was 93% or above for all LHDs except Mid North Coast and Northern NSW ( Table 2 ).
Adolescents
• NSW coverage for all vaccines/antigens at 12 months of age increased in 2017 from 2016, with coverage greater than or equal to 94% for all vaccines except rotavirus ( Figure 2 ). Coverage for all individual vaccines/antigens, excluding rotavirus vaccine, was greater than 94% in all LHDs except Mid North Coast and Northern NSW ( Table 2 ).
• Coverage for rotavirus vaccine in NSW increased by almost 1 percentage point in 2017 to 90.8% ( Figure 3 ) and greater than 93% for all LHDs except for Northern NSW (Table 3 ).
• From 1 October 2016, the coverage calculation of DTPa-containing vaccine at 24 months of age was changed to be assessed as the fourth dose instead of the third dose. This change resulted in reported DTPacontaining vaccine coverage at 24 months of age decreasing in 2017 in all LHDs. In NSW, it decreased by 4 percentage points from 96.3% in 2016 to 92.3% in 2017 (Table 3 , Figure 3 ). • Varicella-containing vaccine coverage at 24 months of age increased in NSW from 92.4% in 2016 to 92.6% in 2017 with coverage 91% or above for all LHDs except for Northern NSW (Table 3 ).
• In 2017, MMR-containing vaccine coverage in NSW at 24 months of age was 95.0% for the first dose and 92.9% for the second dose (Table 3) . Coverage for the second dose of MMR-containing vaccine was greater than 91% for all LHDs except for Northern NSW.
• When assessed at 60 months of age, coverage of the second dose of MMR-containing vaccine in 2017 was 95.7% in NSW and was above 94% in all LHDs except Northern NSW and Northern Sydney (Table 4 ).
• Coverage for all vaccines/antigens for the 60-month milestone in NSW remained greater than 93% in 2017 (Table 4 , Figure 4 ) and was greater than 90% in all LHDs except Northern NSW (Table 4) .
Aboriginal coverage
• In 2017, 'fully immunised' coverage for NSW Aboriginal children at the 12-month milestone continued to
improve, increasing by 0.8 of a percentage point from 2016 to 94.6% (Table 5) , and remained higher than for non-Aboriginal children at the same age (93.7%).
• 'Fully immunised' coverage for Aboriginal children at the 12-month milestone in 2017 was higher compared with non-Aboriginal children in Central Coast, Far West, Mid North Coast, Network with Victoria, Northern NSW, Northern Sydney, South Eastern Sydney, Sydney and Western Sydney LHDs, but lower in the other LHDs (Table 5 ).
• Following the change in the definition of 'fully immunised' at 24 months of age to include a fourth instead of third dose of DTPa-containing vaccine, coverage for NSW Aboriginal children at this milestone decreased by 0.8 of a percentage point from 2016 to 91.4% in 2017 (Table 5 ). This remained higher than for non-Aboriginal (Table 5 ).
• 'Fully immunised' coverage for NSW Aboriginal children at the 60-month milestone continued to improve, increasing from 96.6% in 2016 to 97.0% in 2017 (Table 5 ). This was 4 percentage points higher than coverage for non-Aboriginal children at the same age, which remained stable at 93.1%. • At the 60-month milestone, 'fully immunised' coverage was higher in 2017 for Aboriginal compared with nonAboriginal children in all LHDs (Table 5 ).
• In 2017, coverage estimates for vaccines/antigens at each milestone mostly increased for NSW Aboriginal children compared with 2016. However, coverage of DTPa-containing vaccine at 24 months decreased by almost 5 percentage points. Coverage of DTPa-containing vaccine and polio-containing vaccine at 60 months also decreased slightly (Table 6 ).
• In 2017, coverage estimates for vaccines/antigens at the 12-month milestone were similar in Aboriginal children compared with non-Aboriginal children except for rotavirus vaccine, which was 1.8 percentage points lower in Aboriginal children (Table 6 ).
• Coverage estimates for vaccines/antigens at 24 and 60 months of age remained higher in Aboriginal children compared with non-Aboriginal children (Table 6) . (Table 8 ).
• For both the third dose of DTPa-containing vaccine and the second dose of MMR-containing vaccine, there were greater delays in vaccination for Aboriginal children than for non-Aboriginal children in all LHDs in 2017 (Tables  7 and 8 ). The majority of delayed vaccination was in the 1-,3 months delay category for both Aboriginal and non-Aboriginal children across all LHDs.
Small area coverage
• Coverage by small area (SA3) varied across the state for rotavirus vaccine (76.1%-94.8%) and 13-valent PCV (80.7%-98.1%) measured at the 12-month milestone, and the second dose of MMR-containing vaccine (78.7%-97.9%) measured at the 24-month milestone (Figures 8-10 ).
Adolescent coverage
• Coverage in adolescents varied by vaccine and dose with coverage for varicella lower in 2017 compared with the two doses of HPV vaccine (in both females and males), the dTpa vaccine, and the newly introduced meningococcal ACWY conjugate vaccine ( not had the disease. Coverage for this vaccine decreased from 70% in 2016 to 66% in 2017 (Table 9 ). This was the last year varicella vaccine was offered as part of the school program.
• Coverage of the adolescent dTpa booster vaccine has remained stable since 2014, at around 84%-86% (Table 9 ).
• Coverage of each of the two doses of HPV vaccine in 2017 was higher (2%-3%) in female Year 7 students compared with male students. Completion of the twodose schedule was 1-2 percentage points lower in both females and males when compared with the completion of the three-dose schedule in previous years (Table 9 , Figure 11 ). However, 2017 data are preliminary and only include catch-up vaccination offered to students in Year 8 in Terms 1-2 in 2018. Data are not yet available for catch-up doses given to students in Terms 3-4.
• Coverage of the newly introduced meningococcal ACWY conjugate vaccine in 2017 was 72% and 76% for NSW Year 11 and 12 students, respectively (Table 9) .
Coverage in adults
• The 2017 adult influenza vaccination coverage estimates are based on 6026 respondents in NSW aged 65 years and over. 15 • The proportion of people aged 65 years and over reporting vaccination for influenza in the previous 12 months remained relatively stable between 2002 and 2017 ( Figure 12 ). In 2017, 72.6% of surveyed adults reported they had received influenza vaccine in the previous 12 months.
• Influenza vaccination coverage in 2017 varied by LHD, ranging from 66.2% in Nepean Blue Mountains to 78.3% in Hunter New England (Table 10 ). 
Conclusion
The NSW Immunisation Program has continued to be successfully delivered during 2017 with gains in immunisation coverage seen in many areas. The annual 'fully immunised' coverage estimates for both the 12-month and 60-month milestones increased in 2017. While a decrease in coverage at 24 months of age was seen, this was most likely due to a change in the algorithm for 'fully immunised' at this milestone following the addition of the extra booster dose of DTPa due at 18 months of age.
'Fully immunised' estimates at 12 and 60 months of age have continued to improve in 2017 for Aboriginal children across NSW. The gap in coverage between Aboriginal and non-Aboriginal children in NSW has completely closed and the percentage of 'fully immunised' children continues Almost three-quarters of adults aged 65 years and over who were surveyed in 2017 through the rolling NSW Population Health Survey reported having received seasonal influenza vaccine in the previous 12 months.
The AIR, the NSW School Vaccination Register and the NSW Population Health Survey continue to be essential tools for monitoring the implementation of the National Immunisation Program in NSW. The AIR will become increasingly valuable as a monitoring tool as more adolescent and adult vaccination encounters are reported to it. Continued improvements in overall vaccine coverage have led to greater protection for NSW residents from vaccinepreventable diseases. 
